Company Filing History:
Years Active: 2014
Title: Anne Boland-Auge: Innovator in Gene Therapy
Introduction
Anne Boland-Auge is a prominent inventor based in L'Hay-les-Roses, France. She has made significant contributions to the field of gene therapy, particularly in the treatment of tumors. Her innovative work has led to the development of a patented technology that holds promise for advancing medical treatments.
Latest Patents
Anne Boland-Auge holds a patent for "Recombinant adenoviruses encoding the specific iodine transporter (NIS)." This invention relates to gene therapy and aims to improve the treatment of tumors. The patent showcases her expertise and commitment to enhancing therapeutic options in oncology.
Career Highlights
Throughout her career, Anne has been associated with Aventis Pharma S.A., where she has contributed to groundbreaking research and development in pharmaceuticals. Her work has been instrumental in pushing the boundaries of what is possible in gene therapy.
Collaborations
Anne has collaborated with notable professionals in her field, including Michel Perricaudet and Martin Schlumberger. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Anne Boland-Auge is a trailblazer in the field of gene therapy, with a focus on innovative treatments for tumors. Her contributions and collaborations continue to shape the future of medical science.